Navigation Links
Mindray Appoints Mr. Minghe Cheng as Chief Strategic Officer
Date:9/7/2010

Mindray Appoints Mr. Minghe Cheng as Chief Strategic Officer -- SHENZHEN, China, Sept. 7 /PRNewswire-Asia-FirstCall/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Health Care & Hospitals, Medical Equipment, Medical Pharmaceuticals, Pharmaceuticals, Personnel Announcements Click to view news release full screen  

Mindray Appoints Mr. Minghe Cheng as Chief Strategic Officer

 

SHENZHEN, China, Sept. 7 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced the appointment of Mr. Minghe Cheng as Chief Strategic Officer of the Company, effective as of September 6, 2010. Mr. Cheng's role will primarily include business model development, short and long-term strategic program planning and corporate structure and operation-process optimization.

"Mr. Cheng's extensive breadth of experience with Mindray's strategy and development makes him the ideal choice for this position," commented Mr. Xu Hang, Mindray's Chairman and Co-Chief Executive Officer. "We are confident that Mr. Cheng will continue to add value to Mindray's brand and play an instrumental role in helping the company benefit from new business and market opportunities."

"I look forward to my new role in developing both short and long-term strategic plans for each of our existing product lines as well as searching for new opportunities to aid the rapid and healthy expansion of Mindray's overall business," added Mr. Minghe Cheng. "There is great potential for Mindray, and given our innovative approach and strategic thinking backed by effective operations, we believe we are well-positioned to capitalize on these new opportunities."

As a co-founder of Mindray, Mr. Cheng has served 17 years in various roles across Mindray's sales, marketing and strategic development departments since the Company's establishment. Mr. Cheng received his bachelor's and master's degrees in biomedical engineering from Shanghai Jiaotong University.

About Mindray

We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain our global operational headquarters in Shenzhen, China, and multiple sales offices in major domestic and international markets. From our main manufacturing and engineering base in China and through our worldwide distribution network, we supply internationally a broad range of products across three primary business segments, comprised of patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. For more information, please visit http://ir.mindray.com .

For investor and media inquiries, please contact: In the U.S.: Bryan Armstrong FD Tel: +1-312-553-6707 Email: bryan.armstrong@fd.com John Capodanno FD Tel: +1-212-850-5705 Email: john.capodanno@fd.com In China: Cathy Gao Tel: +86-755-2658-2518 Email: ir@mindray.com
'/>"/>

SOURCE Mindray Medical International Limited
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Mindray Files Annual Report on Form 20-F with U.S. Securities and Exchange Commission
2. Mindray Medical to Present at J.P. Morgan China Conference 2010
3. Mindray Medical Provides Mid-Year Update on Product Development
4. Mindray to Report Second Quarter 2010 Financial Results on August 9, 2010
5. Mindray to Attend the 2010 American Association for Clinical Chemistry Conference
6. Mindray Launches New Premium M7 Portable Ultrasound System in U.S.
7. Mindray Medical to Present at the Goldman Sachs 7th Annual European Medtech and Healthcare Services Conference
8. Mindray Medical to Present at the Morgan Stanley Global Healthcare Conference
9. /C O R R E C T I O N - Mindray Medical International Limited /
10. Quark Pharmaceuticals Appoints New Chief Medical Officer
11. West Pharmaceutical Services, Inc. Appoints New Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who has ... of the current process. Many of them do not even ... technical difficulties and high laboratory costs involved. And those who ... it at such a high cost that the majority of ... Dr. Parsa Zadeh , founder of Dental Evolutions ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating to ... of individuals in the United States and Canada wear eyeglasses. Once considered to be ... vision and make a fashion statement. Even celebrities use glasses as a way of ...
(Date:6/26/2016)... ... 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is helping to ... app. The fitness app plans to fix the two major problems leading the fitness industry ... fits all type program , They don’t eliminate all the reasons people quit ...
(Date:6/25/2016)... ... 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can ... CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn ... X . Simply select a ProHand generator and drag it above media or text ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension ... that it will receive two significant new grants to support its work to ... its 25th anniversary by recognizing patients, medical professionals and scientists for their work ...
Breaking Medicine News(10 mins):